Quick Answer
Arcadia Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $259.0 thousand for the year ending 2025.
- Arcadia Biosciences, Inc. showed a decrease of -93.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Arcadia Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 90.9%.
- Historical annual values: Fiscal year 2025: $259.0 thousand | Fiscal year 2024: $4.24 million | Fiscal year 2023: $6.52 million | Fiscal year 2022: $20.64 million | Fiscal year 2021: $28.69 million | Fiscal year 2020: $14.04 million | Fiscal year 2019: $8.42 million | Fiscal year 2018: $12.00 million | Fiscal year 2017: $9.13 million | Fiscal year 2016: $2.01 million | Fiscal year 2015: $23.97 million | Fiscal year 2014: $16.57 million | Fiscal year 2013: $2.84 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: